Phase 2 open-label extention (OLE) study of patisiran, an investigational siRNA agent for familial amyloidotic polyneuropathy (FAP). Issue 1 (December 2015) - Adams, David; Suhr, Ole; Conceicao, Isabel; Waddington-Cruz, Marcia; Schmidt, Hartmut; Buades, Juan; Campistol, Josep; Coehlo, Teresa